• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于铯和铊促排的普鲁士蓝肠道释放给药系统的制备、表征及药代闪烁显像评估

Preparation, Characterization, and Pharmacoscintigraphy Evaluation of an Intestinal Release Delivery System of Prussian Blue for Decorporation of Cesium and Thallium.

作者信息

Sandal Nidhi, Mittal Gaurav, Bhatnagar Aseem, Pathak Dharam Pal, Singh Ajay Kumar

机构信息

Department of Nuclear Medicine, Institute of Nuclear Medicine and Allied Sciences, Defence R&D Organisation, Brig. SK Mazumdar Road, Delhi 110 054, India.

Division of Pharmaceutical Chemistry, DIPSAR, MB Road, Pushp Vihar, New Delhi 110 017, India.

出版信息

J Drug Deliv. 2017;2017:4875784. doi: 10.1155/2017/4875784. Epub 2017 Nov 29.

DOI:10.1155/2017/4875784
PMID:29318045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5727830/
Abstract

BACKGROUND

Prussian blue (PB, ferric hexacyanoferrate) is approved by US-FDA for internal decorporation of Cesium-137 (Cs) and Thallium-201 (Tl).

AIM

Since PB is a costly drug, pH-dependent oral delivery system of PB was developed using calcium alginate matrix system.

METHODS

Alginate (Alg) beads containing PB were optimized by gelation of sodium alginate with calcium ions and effect of varying polymer concentration on encapsulation efficiency and release profile was investigated. Scanning electron microscopy (SEM) was carried out to study surface morphology. Adsorption efficacy of Alg-PB beads for Tl was evaluated and compared with native PB. pH-dependent release of the formulation was studied in humans using gamma scintigraphy.

RESULTS

Encapsulation efficiencies of Alg-PB beads with 0.5, 1.0, 1.5, and 2.0% polymer solution were 99.9, 91, 92, and 93%, respectively. SEM and particle size analysis revealed differences between formulations in their appearance and size distribution. No drug release was seen in acidic media (pH of 1-2) while complete release was observed at pH of 6.8. Dissolution data was fitted to various mathematical models and beads were found to follow Hixson-Crowell mechanism of release. The pH-dependent release of beads was confirmed by pharmacoscintigraphy in humans.

摘要

背景

普鲁士蓝(PB,六氰合铁酸铁)已获美国食品药品监督管理局批准用于体内去除铯 - 137(Cs)和铊 - 201(Tl)。

目的

由于PB是一种昂贵的药物,因此使用海藻酸钙基质系统开发了PB的pH依赖性口服给药系统。

方法

通过海藻酸钠与钙离子凝胶化优化含PB的海藻酸盐(Alg)珠,并研究不同聚合物浓度对包封效率和释放曲线的影响。进行扫描电子显微镜(SEM)以研究表面形态。评估Alg - PB珠对Tl的吸附效果并与天然PB进行比较。使用γ闪烁显像术在人体中研究该制剂的pH依赖性释放。

结果

聚合物溶液浓度为0.5%、1.0%、1.5%和2.0%的Alg - PB珠的包封效率分别为99.9%、91%、92%和93%。SEM和粒度分析揭示了制剂在外观和尺寸分布上的差异。在酸性介质(pH为1 - 2)中未见药物释放,而在pH为6.8时观察到完全释放。将溶解数据拟合到各种数学模型,发现珠遵循希克森 - 克劳威尔释放机制。通过人体药物闪烁显像术证实了珠的pH依赖性释放。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d2f/5727830/7094857a3dea/JDD2017-4875784.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d2f/5727830/6566ec6d51f8/JDD2017-4875784.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d2f/5727830/e54a06b444bd/JDD2017-4875784.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d2f/5727830/b7678d6a773b/JDD2017-4875784.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d2f/5727830/d190845f1226/JDD2017-4875784.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d2f/5727830/6aadf27cf048/JDD2017-4875784.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d2f/5727830/f232fb772da6/JDD2017-4875784.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d2f/5727830/7094857a3dea/JDD2017-4875784.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d2f/5727830/6566ec6d51f8/JDD2017-4875784.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d2f/5727830/e54a06b444bd/JDD2017-4875784.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d2f/5727830/b7678d6a773b/JDD2017-4875784.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d2f/5727830/d190845f1226/JDD2017-4875784.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d2f/5727830/6aadf27cf048/JDD2017-4875784.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d2f/5727830/f232fb772da6/JDD2017-4875784.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d2f/5727830/7094857a3dea/JDD2017-4875784.007.jpg

相似文献

1
Preparation, Characterization, and Pharmacoscintigraphy Evaluation of an Intestinal Release Delivery System of Prussian Blue for Decorporation of Cesium and Thallium.用于铯和铊促排的普鲁士蓝肠道释放给药系统的制备、表征及药代闪烁显像评估
J Drug Deliv. 2017;2017:4875784. doi: 10.1155/2017/4875784. Epub 2017 Nov 29.
2
pH-dependent Release Matrix Oral Formulation of Prussian Blue to Improve its Efficacy as an Internal Decorporation Agent.基于 pH 值依赖的普鲁士蓝释放基质口服制剂,以提高其作为内部祛染剂的疗效。
Curr Drug Deliv. 2021;18(8):1162-1173. doi: 10.2174/1567201818666210127093327.
3
Oral formulation of Prussian blue with improved efficacy for prophylactic use against thallium.用于预防铊中毒的疗效得到改善的普鲁士蓝口服制剂。
Drug Dev Ind Pharm. 2023 Feb;49(2):149-158. doi: 10.1080/03639045.2023.2189958. Epub 2023 Mar 22.
4
Quantitative determination of cesium binding to ferric hexacyanoferrate: Prussian blue.铯与六氰合铁酸铁(普鲁士蓝)结合的定量测定
J Pharm Biomed Anal. 2008 May 12;47(1):114-25. doi: 10.1016/j.jpba.2007.11.049. Epub 2007 Dec 14.
5
Development and evaluation of a calcium alginate based oral ceftriaxone sodium formulation.基于海藻酸钙的口服头孢曲松钠制剂的研制与评价
Prog Biomater. 2016;5:117-133. doi: 10.1007/s40204-016-0051-9. Epub 2016 Jul 20.
6
Development and evaluation of alginate-chitosan gastric floating beads loading with oxymatrine solid dispersion.载氧化苦参碱固体分散体的海藻酸钠-壳聚糖胃漂浮微丸的研制与评价
Drug Dev Ind Pharm. 2016;42(3):456-63. doi: 10.3109/03639045.2015.1088866. Epub 2015 Sep 30.
7
Physicochemical and pharmacotechnical characterization of Prussian blue for future Prussian blue oral dosage forms formulation.用于未来普鲁士蓝口服剂型配方的普鲁士蓝的物理化学和药剂学特性
Heliyon. 2024 Jan 8;10(2):e24284. doi: 10.1016/j.heliyon.2024.e24284. eCollection 2024 Jan 30.
8
Chemically bound Prussian blue in sodium alginate hydrogel for enhanced removal of Cs ions.海藻酸钠水凝胶中化学结合普鲁士蓝用于增强 Cs 离子的去除
J Hazard Mater. 2018 Oct 15;360:243-249. doi: 10.1016/j.jhazmat.2018.08.031. Epub 2018 Aug 10.
9
Alginate-coated alginate-polyethyleneimine beads for prolonged release of furosemide in simulated intestinal fluid.用于在模拟肠液中长效释放呋塞米的海藻酸盐包被的海藻酸盐-聚乙烯亚胺珠粒
Drug Dev Ind Pharm. 2005 May;31(4-5):435-46. doi: 10.1080/03639040500214647.
10
Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.海藻酸包覆壳聚糖核壳纳米粒经口递送依诺肝素:体外与体内评价。
Int J Pharm. 2013 Nov 1;456(1):31-40. doi: 10.1016/j.ijpharm.2013.08.037. Epub 2013 Aug 29.

引用本文的文献

1
Eriodictyol-cisplatin coated nanomedicine synergistically promote osteosarcoma cells ferroptosis and chemosensitivity.圣草酚-顺铂包被的纳米药物协同促进骨肉瘤细胞铁死亡和化疗敏感性。
J Nanobiotechnology. 2025 Feb 14;23(1):109. doi: 10.1186/s12951-025-03206-3.
2
Photodynamic and Photothermal Therapy of Hepatocellular Carcinoma.肝细胞癌的光动力与光热疗法
Front Oncol. 2021 Dec 7;11:787780. doi: 10.3389/fonc.2021.787780. eCollection 2021.
3
Prussian Blue: A Safe Pigment with Zeolitic-Like Activity.普鲁士蓝:一种具有类沸石活性的安全颜料。

本文引用的文献

1
Removal of Radioactive Cesium Using Prussian Blue Magnetic Nanoparticles.使用普鲁士蓝磁性纳米颗粒去除放射性铯
Nanomaterials (Basel). 2014 Nov 28;4(4):894-901. doi: 10.3390/nano4040894.
2
Synergistically strengthened 3D micro-scavenger cage adsorbent for selective removal of radioactive cesium.协同增强的 3D 微观清除笼状吸附剂,用于选择性去除放射性铯。
Sci Rep. 2016 Dec 5;6:38384. doi: 10.1038/srep38384.
3
Cellulose nanofiber backboned Prussian blue nanoparticles as powerful adsorbents for the selective elimination of radioactive cesium.
Int J Mol Sci. 2021 Jan 15;22(2):780. doi: 10.3390/ijms22020780.
纤维素纳米纤维支撑的普鲁士蓝纳米颗粒作为选择性去除放射性铯的高效吸附剂。
Sci Rep. 2016 Nov 15;6:37009. doi: 10.1038/srep37009.
4
Radiocesium removal system for environmental water and drainage.放射性铯去除系统,用于环境水和排水。
Water Res. 2016 Dec 15;107:29-36. doi: 10.1016/j.watres.2016.10.043. Epub 2016 Oct 18.
5
Hydrogels Containing Prussian Blue Nanoparticles Toward Removal of Radioactive Cesium Ions.含普鲁士蓝纳米颗粒的水凝胶用于去除放射性铯离子
J Nanosci Nanotechnol. 2016 Apr;16(4):4200-4. doi: 10.1166/jnn.2016.12607.
6
Comparison of Absorbents and Drugs for Internal Decorporation of Radiocesium: Advances of Polyvinyl Alcohol Hydrogel Microsphere Preparations Containing Magnetite and Prussian Blue.用于放射性铯体内促排的吸附剂与药物比较:含磁铁矿和普鲁士蓝的聚乙烯醇水凝胶微球制剂的进展
Biol Pharm Bull. 2016;39(3):353-60. doi: 10.1248/bpb.b15-00728. Epub 2015 Dec 25.
7
Pharmacokinetics of colon-specific pH and time-dependent flurbiprofen tablets.结肠特异性pH和时间依赖性氟比洛芬片的药代动力学
Eur J Drug Metab Pharmacokinet. 2015 Sep;40(3):301-11. doi: 10.1007/s13318-014-0210-0. Epub 2014 Jun 11.
8
Efficacy of Prussian blue on 137Cs decorporation therapy.普鲁士蓝在 137Cs 祛铯治疗中的疗效。
Health Phys. 2014 May;106(5):592-7. doi: 10.1097/HP.0000000000000035.
9
Controlled release of diclofenac sodium through acrylamide grafted hydroxyethyl cellulose and sodium alginate.通过丙烯酰胺接枝羟乙基纤维素和海藻酸钠控制释放双氯芬酸钠。
Carbohydr Polym. 2014 Apr 15;104:151-7. doi: 10.1016/j.carbpol.2014.01.018. Epub 2014 Jan 15.
10
Mucoadhesive microspheres containing anti-hypertensive agent: formulation and characterization.含抗高血压药物的黏膜黏附微球:制剂与表征
Curr Drug Deliv. 2014;11(3):322-31. doi: 10.2174/1567201810666140110113225.